Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial-Reference-Cited by-同舟云学术

Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial

Published:2023-02 Issue: Volume:56 Page:101809
ISSN:2589-5370
Container-title:eClinicalMedicine
language:en
Short-container-title:eClinicalMedicine

Author:

von Rotz Robin^ORCID,Schindowski Eva M.^ORCID,Jungwirth Johannes,Schuldt Anna,Rieser Nathalie M.,Zahoranszky Katharina,Seifritz Erich,Nowak Albina,Nowak Peter,Jäncke Lutz,Preller Katrin H.,Vollenweider Franz X.^ORCID

Publisher

Elsevier BV

Subject

General Medicine

Reference25 articles.

1. Burden of depressive disorders by country, sex, age, and year: findings from the Global Burden of Disease Study 2010;Ferrari;PLoS Med,2013

2. Considering the methodological limitations in the evidence base of antidepressants for depression: a reanalysis of a network meta-analysis;Munkholm;BMJ Open,2019

3. Depressive disorders: treatment failures and poor prognosis over the last 50 years;Blackburn;Pharmacol Res Perspect,2019

4. Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study;Carhart-Harris;Lancet Psychiatry,2016

5. Psilocybin with psychological support for treatment-resistant depression: six-month follow-up;Carhart-Harris;Psychopharmacology (Berl),2018

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics of Psilocybin, a Tryptamine Alkaloid in Magic Mushroom ( Psilocybe cubensis ): A Systematic Review;Journal of Psychoactive Drugs;2024-09-10

2. Pharmacological and non-pharmacological predictors of the LSD experience in healthy participants;Translational Psychiatry;2024-09-04

3. Clinically relevant acute subjective effects of psychedelics beyond mystical experience;Nature Reviews Psychology;2024-09-03

4. Considering distinct positive emotions in psychedelic science;International Review of Psychiatry;2024-09-02

5. Psychedelika und Dissoziativa in der Psychiatrie: Herausforderungen in der Behandlung;Der Nervenarzt;2024-08-28